IMPDH2 expression | |||||
---|---|---|---|---|---|
Characteristics | n = 214 | Low (%) | High (%) | P value | x2 |
Gender | 0.083 | 3.014 | |||
Male | 136 | 60(44.1) | 76(55.9) | ||
Female | 78 | 25(32.1) | 53(67.9) | ||
Age (years) | 0.154 | 2.033 | |||
<55 | 106 | 37(34.9) | 69(65.1) | ||
≥ 55 | 108 | 48(44.4) | 60(55.6) | ||
Tumor site | 0.626 | 0.936 | |||
Proximal colon | 47 | 17(36.2) | 30(63.8) | ||
Distal colon | 37 | 13(35.1) | 24(64.9) | ||
Rectum | 130 | 55(42.3) | 75(57.7) | ||
Tumor size (cm) | 0.253 | 1.305 | |||
<5 | 116 | 42(36.2) | 74(63.8) | ||
≥ 5 | 98 | 43(43.9) | 55(56.1) | ||
Tumor differentiation | 0.758 | 0.554 | |||
Well | 81 | 34(42.0) | 47(58.0) | ||
Moderate | 101 | 40(39.6) | 61(60.4) | ||
Poor | 32 | 11(34.4) | 21(65.6) | ||
T stage | 0.048 | 6.057 | |||
T1–2 | 59 | 31(52.5) | 28(47.5) | ||
T3 | 140 | 50(35.7) | 90(64.3) | ||
T4 | 15 | 4(26.7) | 11(73.3) | ||
Lymph node state | < 0.001 | 13.525 | |||
Positive | 88 | 22(25.0) | 66(75.0) | ||
Negative | 126 | 63(50.0) | 63(50.0) | ||
Distant metastasis | 0.026 | 4.962 | |||
Positive | 38 | 9(23.7) | 29(76.3) | ||
Negative | 176 | 76(43.2) | 100(56.8) | ||
Lymphovascular invasion | 0.018 | 5.551 | |||
Positive | 73 | 21(28.8) | 52(71.2) | ||
Negative | 141 | 64(45.4) | 77(54.6) | ||
Clinical stage | 0.001 | 15.697 | |||
1 | 53 | 29(54.7) | 24(45.3) | ||
2 | 63 | 31(49.2) | 32(50.8) | ||
3 | 60 | 16(26.7) | 44(73.3) | ||
4 | 38 | 9(23.7) | 29(76.3) |